Biomedical Engineering Reference
In-Depth Information
12. Risberg, B., Andreasson, S., and Eriksson, E., Disseminated intravascular coagulation,
Acta Anaesthe-
siol. Scand
., 95, 60, 1991.
13. Butenas, S., van't Veer, C., and Mann, K.G., “Normal” thrombin generation,
Blood
, 94, 2169, 1999.
14. Mosesson M.W., Fibrinogen and fi brin polymerization: Appraisal of the binding events that accompany
fi brin generation and fi brin clot assembly,
Blood Coagul. Fibrinol
., 8, 257, 1997.
15. Choay, J. et a l., St r uct u re - activit y relationsh ip in hepa r in: A synt hetic pent asaccha r ide wit h h igh a fi nity
for antithrombin III and eliciting high anti factor Xa activity,
Biochem. Biophys. Res. Comm
., 116,
492, 1983.
16. Naito, K. and Fujikawa, K., Activation of human blood coagulation factor XI independent of factor XII:
Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces,
J. Biol.
Chem
., 266, 7353, 1991.
17. Ofosu, F.A. et al., The inhibition of thrombin-dependent positive-feedback reactions is critical to the
expression of the anticoagulant effect of heparin,
Biochem. J
., 243, 579, 1987.
18. Ofosu, F.A., Liu, L., and Feedman, J., Control mechanisms in thrombin generation,
Semin. Thromb.
Haemost
., 22, 303, 1996.
19. Bereczky, Z., Katona, E., and Muszbek, L., Fibrin stabilization (factor XIII), fi brin structure and
thrombosis,
Pathophysiol. Haemost. Thromb
., 33, 430, 2003.
20. Muszbek, L., Adany, R., and Mikkola, H., Novel aspects of blood coagulation factor XIII. I. Structure,
distribution, activation, and function,
Crit. Rev. Clin. Lab. Sci
., 33, 357, 1996.
21. Devine, D.V. and Bishop, P.D., Platelet-associated factor XIII in platelet activation, adhesion, and clot
stabilization,
Thromb. Haemost
., 22, 409, 1996.
22. Bajzar, L. et al., Both cellular and soluble forms of thrombomodulin inhibit fi brinolysis by potentiating
the activation of thrombin activable fi brinolysis inhibitor,
J. Biol. Chem
., 273, 2792, 1998.
23. Boffa, M.B. et al., Plasma and recombinant thrombin activable fi brinolysis inhibitor (TAFI) and acti-
vated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation,
thermal stability, and enzymatic properties,
J. Biol. Chem
., 273, 2127, 1998.
24. Kokame, K., Zheng, X., and Sadler, J.E., Activation of thrombin activable fi brinolysis inhibitor requires
epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C,
J. Biol. Chem
., 273, 12135, 1998.
25. Dahlback, B., The protein C anticoagulant system: Inherited defects as basis for venous thrombosis,
Thromb. Res
., 77, 1, 1995.
26. Kisiel, W. et al., Anticoagulant properties of bovine plasma protein C following activation by thrombin,
J. Biol. Chem
., 16, 5824, 1977.
27. Chuang, Y.J., Gettins, P.G., and Olson, S.T., Importance of the P2 glycine of antithrombin in target
proteinase specifi city, heparin activation, and the effi ciency of proteinase trapping as revealed by a P2
gly→pro mutation,
J. Biol. Chem
., 274, 28142, 1999.
28. Buller, H.R. and Ten Cate, T., Coagulation and platelet activation pathways. A review of the key compo-
nents and the way in which these can be manipulated,
Eur. Heart J
., 16, 8, 1995.
29. Nilson, I.M., Coagulation and fi brinolysis,
Scand. J. Gastroenterol
., 137, 11, 1987.
30. Jordan, R.E. et al., The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low
molecular weight heparin,
J. Biol. Chem
., 255, 10081, 1980.
31. Rezaie, A.R., Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin
reaction,
Biochemistry
, 35, 1918, 1996.
32. Mille, B. et al., Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide,
J. Biol. Chem
., 269, 29435, 1994.
33. Olson, S.T. and Chuang, Y.J., Heparin activates antithrombin anticoagulant function by generating new
interaction sites (exosites) for blood clotting proteinases,
Trends Cardiovasc. Med
., 12, 331, 2002.
34. Danielsson, A.E. et al., Role of ternary complexes, in which heparin binds both antithrombin and pro-
teinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa,
J. Biol.
Chem
., 261, 15467, 1986.
35. Byun, Y., Jacobs, H.A., and Kim, S.W., Mechanism of thrombin inactivation by immobilized heparin,
J. Biomed. Mater. Res
., 30, 423, 1996.
36. Cundiff, D.K., Anticoagulation therapy thromboembolism,
Med. Gen. Med.
, 6, 5, 2004.
37. Vincentelli, A., Jude, B., and Belisle, S., Antithrombotic therapy in cardiac surgery,
Can. J. Anaesth
.,
53, S89, 2006.
38. Estes, J.W., Pelikan, E.W., and Kruger-Thiemer, E., A retrospective study of the pharmacokinetics of
heparin,
Clin. Pharmacol. Ther
., 10, 329, 1969.
